347 related articles for article (PubMed ID: 12652979)
1. [Drug resistant tuberculosis in children and adolescents].
Aksenova VA; Luginova EF
Probl Tuberk; 2003; (1):25-8. PubMed ID: 12652979
[TBL] [Abstract][Full Text] [Related]
2. [Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents].
Panova LV; Ovsiankina ES
Probl Tuberk Bolezn Legk; 2007; (5):20-2. PubMed ID: 17600925
[TBL] [Abstract][Full Text] [Related]
3. [Efficiency of preventive chemotherapy in children and adolescents from the bacterial isolation foci of tuberculous infection].
Ovsiankina ES; Kasimtseva OV; Vasil'eva IA
Probl Tuberk Bolezn Legk; 2006; (1):3-6. PubMed ID: 16512175
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes].
Vasil'eva IA; Andreevskaia SN; Smirnova TG; Chernousova LI; Chukanov VI
Probl Tuberk Bolezn Legk; 2004; (8):25-8. PubMed ID: 15478554
[TBL] [Abstract][Full Text] [Related]
5. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
Belianin II; Shmelev EI
Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance].
Mishin VIu; Chukanov VI; Vasil'eva IA
Probl Tuberk; 2002; (12):18-23. PubMed ID: 12611329
[TBL] [Abstract][Full Text] [Related]
7. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
Gubkina MF; Ershova NG
Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
[TBL] [Abstract][Full Text] [Related]
8. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
[TBL] [Abstract][Full Text] [Related]
9. [A role of the biological chip test in the determination of rifampicin resistance in Mycobacteria in adolescents with active pulmonary tuberculosis].
Firsova VA; Poluektova FG; Kuz'min AV; Chernousova LN
Probl Tuberk Bolezn Legk; 2004; (8):28-30. PubMed ID: 15478555
[TBL] [Abstract][Full Text] [Related]
10. [Ways of overcoming drug resistance in patients with pulmonary tuberculosis].
Grishin MN; Svistov VV; Krivoshein IuS
Probl Tuberk; 2002; (3):16-8. PubMed ID: 12066525
[TBL] [Abstract][Full Text] [Related]
11. [The rate and pattern of drug resistance in Mycobacterium tuberculosis at various sites of the disease].
Vishnevskiĭ BI; Steklova LN
Probl Tuberk Bolezn Legk; 2008; (12):5-8. PubMed ID: 19227317
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
13. [Etiopathogenetic therapy in adolescent patients with drug-resistant Mycobacterium tuberculosis in respiratory tuberculosis].
Pavlova MV; Skvortsova LA; Kondakova MN; Sapozhnikova NV
Probl Tuberk Bolezn Legk; 2004; (1):24-6. PubMed ID: 15137140
[TBL] [Abstract][Full Text] [Related]
14. [The clinical features of tuberculosis in children and adolescents excreting drug-resistant Mycobacterium tuberculosis strains].
Bekembaeva GS; Serikbaeva KS; Kastypkaeva DV
Probl Tuberk Bolezn Legk; 2009; (6):13-6. PubMed ID: 19642567
[No Abstract] [Full Text] [Related]
15. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
[TBL] [Abstract][Full Text] [Related]
16. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM
Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020
[TBL] [Abstract][Full Text] [Related]
17. [New technologies in the determination of drug susceptibility in Mycobacterium tuberculosis].
Skotnikova OI; Mikhaĭlovich VM; Nosova EIu; Lapa SA; Griadunov DA; Donnikov MIu; Badleeva MV; Galkina KIu; Dorozhkova IR; Litvinov VI; Zasedatelev AS; Moroz AM; Mirzabekov AD
Probl Tuberk Bolezn Legk; 2004; (6):40-2. PubMed ID: 15315132
[TBL] [Abstract][Full Text] [Related]
18. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
Khodashova ML; Iuditskiĭ MV; Semenova OV
Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
[TBL] [Abstract][Full Text] [Related]
19. [Artificial pneumoperitoneum in the complex treatment of pulmonary tuberculosis patients isolating drug-resistant mycobacterium tuberculosis].
Bagdasarian TR; Vasil'eva IA; Sigaev AT; Chukanov VI
Probl Tuberk Bolezn Legk; 2006; (8):23-6. PubMed ID: 17002053
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
